CDKN2A and glioma: Gain-of-function mutations in CDK4 are seen, in GBM, activating the RB pathway.109 Bmi1, a promoter of neural stem cell self-renewal and neural development, is expressed in most gliomas and promotes malignancy in p16Ink4a/p19ARF double-null murine gliomas.